About Nusinersen
            
            Class: | Antisense oligonucleotide  
Use: | Treatment of spinal muscular atrophy (SMA) in pediatric and adult patients  
Adult dose: | 12 mg (3 mL) administered intrathecally once every 4 months after an initial loading dose of 12 mg (3 mL) on days 0, 14, and 28  
Pediatric dose: | 12 mg (3 mL) administered intrathecally once every 4 months after an initial loading dose of 12 mg (3 mL) on days 0, 14, and 28 for patients with SMA  
Side effects: | Common side effects include headache, back pain, 
         
        
            
                
                
                    
                        Drug Class
                    
                    Antisense oligonucleotide
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of spinal muscular atrophy (SMA) in pediatric and adult patients
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Biogen Idec Inc., U.S.A
                    
                    
                    Package Size
                    5ml Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 463742.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        12 mg (3 mL) administered intrathecally once every 4 months after an initial loading dose of 12 mg (3 mL) on days 0, 14, and 28
                    
                    
                        Pediatric Dose
                    
                    
                        12 mg (3 mL) administered intrathecally once every 4 months after an initial loading dose of 12 mg (3 mL) on days 0, 14, and 28 for patients with SMA
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include headache, back pain, nausea, vomiting, constipation, and respiratory infections
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to nusinersen or any component of the formulation; caution in patients with bleeding disorders or those on anticoagulant therapy
         
        
        
            
                Important Warnings
            
            Risk of serious neurological adverse reactions; monitor for signs of infection; potential for thrombocytopenia; ensure proper administration technique to avoid complications such as post-lumbar puncture headache or infection
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.